| A Clinical Trial to Investigate Efficacy, Safety and Pharmacokinetics (PK) of Two LXE408 Oral Regimens and Oral Miltefosine as Active Control in Participants Aged ≥ 18 Years Old With Localized Cutaneous Leishmaniasis in the Region of the Americas (AMR). (NCT06997159) | Drugs for Neglected Diseases | 2026-06-15 |
| Mycetoma Retrospective Data Collection (NCT06512714) | Drugs for Neglected Diseases | 2024-06-20 |
| Stop Transmission of Gambiense Human African Trypanosomiasis (STROgHAT) (NCT06356974) | Drugs for Neglected Diseases | 2024-04-08 |
| LXE408 for Treatment of Visceral Leishmaniasis in Ethiopia, a Proof of Concept Study (NCT05957978) | Drugs for Neglected Diseases | 2024-03-29 |
| DDI Study of Single Oral Dose of Acoziborole With Sequential Co-administration of Midazolam and Dextromethorphan (NCT05947604) | Drugs for Neglected Diseases | 2023-02-09 |
| Eumycetoma Long-term Post-Treatment Follow-Up Study (NCT06514183) | Drugs for Neglected Diseases | 2023-01-26 |
| A Phase II, Multicentre, Randomized, Two-arm Blinded Study to Assess the Efficacy and Safety of Two LXE408 Regimens for Treatment of Patients With Primary Visceral Leishmaniasis (NCT05593666) | Drugs for Neglected Diseases | 2022-12-27 |
| Pharmacokinetic, Efficacy, Safety and Tolerability Study of a Single Dose of Acoziborole in g-HAT Paediatric Patients (NCT05433350) | Drugs for Neglected Diseases | 2022-07-09 |
| Safety and Tolerability Study of Acoziborole in g-HAT Seropositive Subjects (NCT05256017) | Drugs for Neglected Diseases | 2021-12-30 |
| Emodepside Phase II Trial for Treatment of Onchocerciasis (NCT05180461) | Drugs for Neglected Diseases | 2021-08-30 |
| ADME Study of Acoziborole in Healthy Subjects (NCT04270981) | Drugs for Neglected Diseases | 2020-02-05 |
| Fexinidazole in Human African Trypanosomiasis Due to T. b. Rhodesiense (NCT03974178) | Drugs for Neglected Diseases | 2019-09-29 |
| Lopinavir/r/ Lamivudine/ Abacavir as an Easy to Use Paediatric Formulation (NCT03836833) | Drugs for Neglected Diseases | 2019-06-04 |
| Single Oral Dose Escalation Study of DNDI-0690 in Healthy Subjects (NCT03929016) | Drugs for Neglected Diseases | 2019-04-04 |
| Study to Investigate Effect of Food and Safety of a New Formulation of Zoliflodacin (NCT03718806) | Drugs for Neglected Diseases | 2018-10-03 |
| NeoAMR Observational Study in Neonatal Sepsis (NCT03721302) | Drugs for Neglected Diseases | 2018-08-16 |
| A Phase 1 Bioequivalence Study of a Test Tablet Formulation of Ravidasvir With the Reference Tablet Formulation of Ravidasvir Study (NCT03602300) | Drugs for Neglected Diseases | 2018-06-05 |
| Short Course Regimens for Treatment of PKDL (Sudan) (NCT03399955) | Drugs for Neglected Diseases | 2018-05-09 |
| Intravenous and Oral Fosfomycin in Hospitalised Neonates With Clinical Sepsis (NCT03453177) | Drugs for Neglected Diseases | 2018-03-15 |
| Miltefosine/Paromomycin Phase III Trial for Treatment of Primary Visceral Leishmaniasis (VL) Patients in Eastern Africa (NCT03129646) | Drugs for Neglected Diseases | 2018-01-24 |
| Safety, Tolerability and PK of Multiple-ascending Doses of Emodepside (NCT03383614) | Drugs for Neglected Diseases | 2017-11-14 |
| Oral Fexinidazole Dosing Regimens for the Treatment of Adults With Chronic Indeterminate Chagas Disease (NCT03587766) | Drugs for Neglected Diseases | 2017-11-13 |
| Relative Bioavailability Study of Emodepside IR-tablets and Solution (NCT03383523) | Drugs for Neglected Diseases | 2017-10-26 |